Internet Archive Scholar

Efficacy and safety of immune checkpoint inhibitors in neoadjuvant chemotherapy for triple-negative breast cancer:a systematic review and meta-analysis [report]

Zheng Xu, Yuxin Song, Di Xu, Yinjiao Fei, Jinhai Tang, Jian Zhang
2021 unpublished

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (74.7 kB)
https://web.archive.org/web/20220519041620/https://inplasy.com/wp-content/uploads/2021/08/INPLASY-Protocol-2079.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Review question / Objective: We want to conduct a systematic review and metaanalysis of a number of randomized controlled trials (RCTs) to provide the latest evidence on the controversial role of drugs in neoadjuvant chemotherapy in patients with triple negative breast cancer. Condition being studied: Triple negative breast cancer. INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols INPLASY PROTOCOL Efficacy and safety of immune checkpoint inhibitors in
more » ... eoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
doi:10.37766/inplasy2021.8.0040 fatcat:5smaahfnjbaizeutjftthfwoju
Citation

Zheng Xu, Yuxin Song, Di Xu, Yinjiao Fei, Jinhai Tang, Jian Zhang. "Efficacy and safety of immune checkpoint inhibitors in neoadjuvant chemotherapy for triple-negative breast cancer:a systematic review and meta-analysis." (2021)